BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25952971)

  • 1. Effects of parathyroid hormone on cortical porosity, non-enzymatic glycation and bone tissue mechanics in rats with type 2 diabetes mellitus.
    Campbell GM; Tiwari S; Hofbauer C; Picke AK; Rauner M; Huber G; Peña JA; Damm T; Barkmann R; Morlock MM; Hofbauer LC; Glüer CC
    Bone; 2016 Jan; 82():116-21. PubMed ID: 25952971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin therapy on porosity, non-enzymatic glycation and mechanical competence in the bone of rats with type 2 diabetes mellitus.
    Campbell GM; Tiwari S; Picke AK; Hofbauer C; Rauner M; Morlock MM; Hofbauer LC; Glüer CC
    Bone; 2016 Oct; 91():186-93. PubMed ID: 27497735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus.
    Hamann C; Picke AK; Campbell GM; Balyura M; Rauner M; Bernhardt R; Huber G; Morlock MM; Günther KP; Bornstein SR; Glüer CC; Ludwig B; Hofbauer LC
    Endocrinology; 2014 Apr; 155(4):1197-206. PubMed ID: 24467747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy.
    Picke AK; Gordaliza Alaguero I; Campbell GM; Glüer CC; Salbach-Hirsch J; Rauner M; Hofbauer LC; Hofbauer C
    Bone; 2016 Jan; 82():108-15. PubMed ID: 26055107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.
    Zhou H; Shen V; Dempster DW; Lindsay R
    J Bone Miner Res; 2001 Jul; 16(7):1300-7. PubMed ID: 11450706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biosynthetic human parathyroid hormone (1-34) effects on bone quality in aged ovariectomized rats.
    Sato M; Zeng GQ; Turner CH
    Endocrinology; 1997 Oct; 138(10):4330-7. PubMed ID: 9322947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of daily treatment with parathyroid hormone 1-84 for 16 months on density, architecture and biomechanical properties of cortical bone in adult ovariectomized rhesus monkeys.
    Fox J; Miller MA; Newman MK; Recker RR; Turner CH; Smith SY
    Bone; 2007 Sep; 41(3):321-30. PubMed ID: 17573250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro non-enzymatic ribation reduces post-yield strain accommodation in cortical bone.
    Willett TL; Sutty S; Gaspar A; Avery N; Grynpas M
    Bone; 2013 Feb; 52(2):611-22. PubMed ID: 23178516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties.
    Lotinun S; Evans GL; Bronk JT; Bolander ME; Wronski TJ; Ritman EL; Turner RT
    J Bone Miner Res; 2004 Jul; 19(7):1165-71. PubMed ID: 15177000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits.
    Hirano T; Burr DB; Turner CH; Sato M; Cain RL; Hock JM
    J Bone Miner Res; 1999 Apr; 14(4):536-45. PubMed ID: 10234574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
    Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
    J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bone architecture is enhanced with combined PTH and alendronate treatment compared to monotherapy while maintaining the state of surface mineralization in the OVX rat.
    Campbell GM; Bernhardt R; Scharnweber D; Boyd SK
    Bone; 2011 Aug; 49(2):225-32. PubMed ID: 21515436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S; Takizawa M; Stein B; Katz IA; Joffe II; Romero DF; Liang XG; Li M; Ke HZ; Jee WS
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice.
    Pierroz DD; Bouxsein ML; Rizzoli R; Ferrari SL
    Bone; 2006 Aug; 39(2):260-7. PubMed ID: 16531131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined humanPTH(1-34) and calcitonin treatment in ovariectomized rats.
    Washimi Y; Ito M; Morishima Y; Taguma K; Ojima Y; Uzawa T; Hori M
    Bone; 2007 Nov; 41(5):786-93. PubMed ID: 17707708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus.
    Hamann C; Rauner M; Höhna Y; Bernhardt R; Mettelsiefen J; Goettsch C; Günther KP; Stolina M; Han CY; Asuncion FJ; Ominsky MS; Hofbauer LC
    J Bone Miner Res; 2013 Mar; 28(3):627-38. PubMed ID: 23109114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.